Identifying brain biomarkers for cognitive rehabilitation in schizophrenia
Official title: Optimization of Neurophysiologic Biomarkers for Rehabilitation Interventions in Veterans With Chronic Psychosis
Run by VA Office of Research and Development · NCT05945602 · Data updated 2026-11-12
This study is trying to find brain markers that can help identify Veterans with schizophrenia who would benefit most from cognitive rehabilitation therapies.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (San Diego, California) |
| Status | Recruiting |
| Started | October 1, 2023 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | October 9, 2025 |
| Trial ID | NCT05945602 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Veterans diagnosed with schizophrenia or other chronic psychotic disorders, as well as healthy Veterans in good general health.
✕Probably not a fit
Patients with active substance use or significant medical or neurological illnesses may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop brain-based tools to identify Veterans with schizophrenia who are most likely to benefit from cognitive rehabilitation therapies. It involves comprehensive neurophysiological, clinical, cognitive, and functional assessments of Veterans diagnosed with schizophrenia and healthy controls at the VA San Diego Healthcare System. The study is conducted in two phases: the first phase focuses on optimizing neurophysiological biomarkers linked to brain function, while the second phase evaluates these biomarkers' sensitivity to cognitive training interventions. The ultimate goal is to enhance the effectiveness of cognitive remediation for improving daily functioning in Veterans with chronic psychosis.
Why it matters
Potential benefit: If successful, this study could lead to improved cognitive rehabilitation strategies for Veterans with schizophrenia, enhancing their daily functioning and quality of life.
How similar studies have gone: While cognitive remediation has shown some benefits in schizophrenia, this approach of using neurophysiological biomarkers for patient selection is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Have a DSM-5 diagnosis of a chronic psychotic disorder (e.g., schizophrenia, schizoaffective disorder, or delusional disorder); or b) are in good general mental and physical health (i.e., no active mental health condition). 2. Fluent in spoken and written English. 3. No impairment in hearing or vision. Exclusion Criteria: 1. Active substance other than cannabis within the last 30 days as determined by self-report or positive urine toxicology (obtained as part of the screening process). 2. History of significant medical or neurological illness or intellectual disability. 3. Inability to comprehend or provide informed consent. 4. Specific to healthy comparison subjects: past or present diagnosis of schizophrenia, schizoaffective disorder, or other chronic psychotic disorder.
Where it's running
-
VA San Diego Healthcare System, San Diego, CA
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Juan Molina, MD — VA San Diego Healthcare System, San Diego, CA
- Study coordinator: Juan Molina, MD
- Email: Juan.Molina@va.gov
- Phone: (202) 555-8975
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Yoga-based group program plus usual care for outpatients with schizophrenia spectrum disorders
This project will see if a 12-week yoga-based group program added to usual outpatient care helps adults with schizophrenia spectrum disorders reduce stress and symptom-related distress compared with exercise or usual care alone.
-
Trying the Kiso Mind smartphone app for people with schizophrenia spectrum disorders
This study tests whether the Kiso Mind smartphone app is acceptable, practical, and helpful for adults with schizophrenia or schizoaffective disorder alongside their usual care.
-
Culturally adapted CBT for psychosis in Black people in the UK
A small series tests whether culturally tailored cognitive-behavioral therapy for psychosis is doable, acceptable, and safe for Black Sub-Saharan African and Caribbean individuals in the UK.
-
Mobile intervention to help homeless veterans with serious mental illness integrate into the community
This study is testing a new mobile program to help homeless veterans with serious mental health issues better connect with their community and find stable housing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.